Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
9250 | 1174 | 47.8 | 94% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
636 | 3 | TIGHT JUNCTION//NOONAN SYNDROME//CLAUDIN | 12838 |
1574 | 2 | TIGHT JUNCTION//NOONAN SYNDROME//CLAUDIN | 7292 |
9250 | 1 | SHP2//SHP 2//SHP 1 | 1174 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | SHP2 | authKW | 1111796 | 7% | 50% | 86 |
2 | SHP 2 | authKW | 682758 | 6% | 37% | 71 |
3 | SHP 1 | authKW | 645005 | 6% | 34% | 72 |
4 | GAB1 | authKW | 618068 | 3% | 61% | 39 |
5 | GAB2 | authKW | 318567 | 2% | 44% | 28 |
6 | PTPN11 | authKW | 177498 | 3% | 21% | 32 |
7 | SHP1 | authKW | 141582 | 1% | 39% | 14 |
8 | SHP2 INHIBITORS | authKW | 133754 | 1% | 86% | 6 |
9 | MOTHEATEN | authKW | 92883 | 0% | 71% | 5 |
10 | PROTEIN TYROSINE PHOSPHATASE | authKW | 90415 | 5% | 6% | 61 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Cell Biology | 3938 | 30% | 0% | 357 |
2 | Biochemistry & Molecular Biology | 3287 | 45% | 0% | 526 |
3 | Oncology | 909 | 16% | 0% | 189 |
4 | Immunology | 757 | 14% | 0% | 161 |
5 | Hematology | 638 | 8% | 0% | 92 |
6 | Genetics & Heredity | 247 | 7% | 0% | 87 |
7 | Medicine, Research & Experimental | 203 | 6% | 0% | 71 |
8 | Biophysics | 83 | 4% | 0% | 49 |
9 | Pathology | 64 | 3% | 0% | 33 |
10 | Developmental Biology | 38 | 2% | 0% | 18 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | IMMUNOL INNOVAT BASE POST EDUC GUIZHOU PROV | 78024 | 0% | 100% | 3 |
2 | PROGRAM STEM CELLS REGENERAT | 72240 | 0% | 56% | 5 |
3 | MARRY BABB RANDOLPH CANC | 69352 | 0% | 67% | 4 |
4 | BIOTECHNOL MOLEC BIOL SECT | 52016 | 0% | 100% | 2 |
5 | MOL ONCOL GRP H5 10 | 52016 | 0% | 100% | 2 |
6 | HIGH THROUGHPUT SCREENING CHEM CORE IL | 46812 | 0% | 60% | 3 |
7 | CHEM GENOM CORE IL | 42550 | 1% | 27% | 6 |
8 | MOL ONCOL C7 | 42550 | 1% | 27% | 6 |
9 | AFFILIATED HOSP 2 HEMATOL | 26008 | 0% | 100% | 1 |
10 | ANAT MOL BIOL GENET | 26008 | 0% | 100% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | JOURNAL OF BIOLOGICAL CHEMISTRY | 4945 | 15% | 0% | 172 |
2 | MOLECULAR AND CELLULAR BIOLOGY | 3727 | 5% | 0% | 57 |
3 | ONCOGENE | 2856 | 4% | 0% | 45 |
4 | JOURNAL OF IMMUNOLOGY | 2096 | 6% | 0% | 67 |
5 | CELLULAR SIGNALLING | 1147 | 1% | 0% | 14 |
6 | CELL COMMUNICATION AND SIGNALING | 1099 | 0% | 1% | 4 |
7 | EXPERIMENTAL HEMATOLOGY | 748 | 1% | 0% | 13 |
8 | BLOOD | 724 | 3% | 0% | 32 |
9 | JOURNAL OF EXPERIMENTAL MEDICINE | 516 | 1% | 0% | 16 |
10 | SEMINARS IN IMMUNOLOGY | 464 | 0% | 0% | 4 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | SHP2 | 1111796 | 7% | 50% | 86 | Search SHP2 | Search SHP2 |
2 | SHP 2 | 682758 | 6% | 37% | 71 | Search SHP+2 | Search SHP+2 |
3 | SHP 1 | 645005 | 6% | 34% | 72 | Search SHP+1 | Search SHP+1 |
4 | GAB1 | 618068 | 3% | 61% | 39 | Search GAB1 | Search GAB1 |
5 | GAB2 | 318567 | 2% | 44% | 28 | Search GAB2 | Search GAB2 |
6 | PTPN11 | 177498 | 3% | 21% | 32 | Search PTPN11 | Search PTPN11 |
7 | SHP1 | 141582 | 1% | 39% | 14 | Search SHP1 | Search SHP1 |
8 | SHP2 INHIBITORS | 133754 | 1% | 86% | 6 | Search SHP2+INHIBITORS | Search SHP2+INHIBITORS |
9 | MOTHEATEN | 92883 | 0% | 71% | 5 | Search MOTHEATEN | Search MOTHEATEN |
10 | PROTEIN TYROSINE PHOSPHATASE | 90415 | 5% | 6% | 61 | Search PROTEIN+TYROSINE+PHOSPHATASE | Search PROTEIN+TYROSINE+PHOSPHATASE |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | HUANG, WQ , LIN, Q , ZHUANG, X , CAI, LL , RUAN, RS , LU, ZX , TZENG, CM , (2014) STRUCTURE, FUNCTION, AND PATHOGENESIS OF SHP2 IN DEVELOPMENTAL DISORDERS AND TUMORIGENESIS.CURRENT CANCER DRUG TARGETS. VOL. 14. ISSUE 6. P. 567 -588 | 137 | 68% | 7 |
2 | TAJAN, M , SERRA, AD , VALET, P , EDOUARD, T , YART, A , (2015) SHP2 SAILS FROM PHYSIOLOGY TO PATHOLOGY.EUROPEAN JOURNAL OF MEDICAL GENETICS. VOL. 58. ISSUE 10. P. 509 -525 | 134 | 61% | 4 |
3 | ZHANG, J , ZHANG, F , NIU, RF , (2015) FUNCTIONS OF SHP2 IN CANCER.JOURNAL OF CELLULAR AND MOLECULAR MEDICINE. VOL. 19. ISSUE 9. P. 2075 -2083 | 62 | 70% | 7 |
4 | WOHRLE, FU , DALY, RJ , BRUMMER, T , (2009) FUNCTION, REGULATION AND PATHOLOGICAL ROLES OF THE GAB/DOS DOCKING PROTEINS.CELL COMMUNICATION AND SIGNALING. VOL. 7. ISSUE . P. - | 105 | 45% | 74 |
5 | POOLE, AW , JONES, ML , (2005) A SHPING TALE: PERSPECTIVES ON THE REGULATION OF SHP-1 AND SHP-2 TYROSINE PHOSPHATASES BY THE C-TERMINAL TAIL.CELLULAR SIGNALLING. VOL. 17. ISSUE 11. P. 1323-1332 | 60 | 87% | 97 |
6 | GROSSMANN, KS , ROSARIO, M , BIRCHMEIER, C , BIRCHMEIER, W , (2010) THE TYROSINE PHOSPHATASE SHP2 IN DEVELOPMENT AND CANCER.ADVANCES IN CANCER RESEARCH, VOL 106. VOL. 106. ISSUE . P. 53-89 | 85 | 48% | 65 |
7 | DING, CB , YU, WN , FENG, JH , LUO, JM , (2015) STRUCTURE AND FUNCTION OF GAB2 AND ITS ROLE IN CANCER (REVIEW).MOLECULAR MEDICINE REPORTS. VOL. 12. ISSUE 3. P. 4007 -4014 | 55 | 69% | 8 |
8 | LI, SM , (2016) THE BIOLOGICAL FUNCTION OF SHP2 IN HUMAN DISEASE.MOLECULAR BIOLOGY. VOL. 50. ISSUE 1. P. 22 -27 | 53 | 78% | 0 |
9 | MATOZAKI, T , MURATA, Y , SAITO, Y , OKAZAWA, H , OHNISHI, H , (2009) PROTEIN TYROSINE PHOSPHATASE SHP-2: A PROTO-ONCOGENE PRODUCT THAT PROMOTES RAS ACTIVATION.CANCER SCIENCE. VOL. 100. ISSUE 10. P. 1786 -1793 | 58 | 67% | 59 |
10 | BUTTERWORTH, S , OVERDUIN, M , BARR, AJ , (2014) TARGETING PROTEIN TYROSINE PHOSPHATASE SHP2 FOR THERAPEUTIC INTERVENTION.FUTURE MEDICINAL CHEMISTRY. VOL. 6. ISSUE 12. P. 1423 -1437 | 60 | 55% | 5 |
Classes with closest relation at Level 1 |